AUS
NZ
UK
CA
USA
IND
Healthcare
Eli Lilly (NYSE:LLY) Tracks Clinical Pipeline Growth In S&P 500 Fund
April 02, 2026 09:20 AM PDT| By Anmol KhazanchiEli Lilly (NYSE:LLY) develops therapies across major healthcare segments, with global operations and research capabilities reflecting its position within the S&P 500 Fund.
Moderna (NASDAQ:MRNA) Target Update Sparks Nasdaq 100 Index Focus
April 02, 2026 09:11 AM PDT| By Anmol KhazanchiModerna (NASDAQ:MRNA) reflects changing biotech sentiment with price target updates and strong liquidity amid Nasdaq 100 index trends.
Intuitive Surgical (NASDAQ:ISRG) Rating Shift Sparks Nasdaq Today Focus
April 02, 2026 08:35 AM PDT| By Anmol KhazanchiIntuitive Surgical (NASDAQ:ISRG) reflects rating changes, strong operational performance, and market positioning amid Nasdaq today movements.
National Research (NASDAQ:NRC) Breaks Key Trendline Amid Nasdaq Index Momentum
April 02, 2026 08:18 AM PDT| By Anmol KhazanchiNational Research (NASDAQ:NRC) gains attention as share price crosses key levels, supported by institutional activity and healthcare analytics positioning within Nasdaq index trends.
Biogen (NASDAQ:BIIB) Target Revision Sparks Nasdaq Futures Focus
April 02, 2026 08:10 AM PDT| By Anmol KhazanchiBiogen (NASDAQ:BIIB) reflects valuation shifts, institutional engagement, and biotechnology sector positioning amid Nasdaq futures activity.
Eli Lilly (NYSE:LLY) Expands Neuroscience Reach Driving Growth In S&P 500
April 01, 2026 01:17 PM PDT| By Anmol KhazanchiThe healthcare and biopharmaceutical sector continues to evolve as companies expand pipelines beyond traditional focus areas. Has long been recognised for its presence in metabolic therapies, particularly in diabetes and obesity care.
Atea Pharmaceuticals (NASDAQ:AVIR) Trading Surge Draws Market Attention
April 01, 2026 08:18 AM PDT| By Anmol KhazanchiAtea Pharmaceuticals (NASDAQ:AVIR) records stock movement driven by biotech developments and Nasdaq futures trends shaping market sentiment.
Protagonist Therapeutics (NASDAQ:PTGX) Surges To New High Amid Nasdaq Today Focus
April 01, 2026 07:58 AM PDT| By Anmol KhazanchiProtagonist Therapeutics (NASDAQ:PTGX) records strong price movement, institutional activity, and biotech positioning amid Nasdaq today trends.
Eli Lilly and Company (NYSE:LLY) Moves Within Russell 1000 Index Landscape
March 31, 2026 12:48 PM PDT| By Anmol KhazanchiEli Lilly (NYSE:LLY) develops global pharmaceutical therapies across multiple segments, with strong research capabilities and market presence aligned with the Russell 1000 Index.
Pfizer Inc. (NYSE:PFE) Tracks Healthcare Allocation In S&P 500 fund
March 31, 2026 10:56 AM PDT| By Anmol KhazanchiPfizer (NYSE:PFE) delivers medicines and vaccines across global markets, with diversified operations and strong presence aligned with broader healthcare activity within the S&P 500 Fund.
Biogen (NASDAQ:BIIB) Stock Gap Movement Draws Nasdaq Composite Focus
March 31, 2026 10:12 AM PDT| By Anmol KhazanchiBiogen (NASDAQ:BIIB) shows gap-down movement amid therapy approval and sector shifts, aligning with Nasdaq composite dynamics.
Eli Lilly (NYSE:LLY) Expands Pharmaceutical Reach Amid Strong Market Activity
March 30, 2026 12:55 PM PDT| By Anmol KhazanchiThe pharmaceutical sector plays a critical role in advancing healthcare through research, development, and global distribution of therapies. Companies within this space focus on addressing complex medical conditions.
Pfizer Developments Draw Attention Across Market Benchmarks
March 29, 2026 10:33 AM PDT| By Team Kalkine MediaHighlights,Recent developments in pharmaceutical research continue to shape Pfizer’s position within the healthcare sector.,Shifts in external regulatory discourse and therapeutic progress remain central to broader market attention.,Major US indices...
AstraZeneca (NYSE:AZN) Gains Sharply Amid Rising Healthcare Market Strength
March 27, 2026 04:12 PM PDT| By Anmol KhazanchiAstraZeneca operates within the global healthcare and biopharmaceutical sector, a field focused on the discovery, development, and distribution of medicines that address complex diseases.
Teleflex (NYSE:TFX) Rally Continues After Upgrade Catches Russell 1000 Index Watchers
March 27, 2026 04:04 PM PDT| By Anmol KhazanchiThe healthcare technology sector continues to play a vital role in advancing clinical outcomes through specialized devices and solutions. Within this space, Teleflex Incorporated operates as a global provider of medical technologies designed.
Title Zimmer Biomet Stability (NYSE:ZBH) How S&P 500 Trends Shape Confidence
March 27, 2026 12:36 PM PDT| By Anmol KhazanchiZimmer Biomet Holdings operates within the global healthcare equipment and orthopaedic solutions space, a segment that supports surgical procedures, joint reconstruction, and mobility restoration.
Bausch And Lomb (NYSE:BLCO) Shares Draw Eyes Across Nyse Composite Today
March 27, 2026 12:05 PM PDT| By Anmol KhazanchiBausch and Lomb operates within the global eye care segment, a healthcare category focused on vision products, surgical solutions, and pharmaceutical treatments. The sector includes contact lenses, intraocular lenses.
Enanta (NASDAQ:ENTA) Biotech Momentum Builds Across Nasdaq Index
March 27, 2026 09:02 AM PDT| By Anmol KhazanchiEnanta Pharmaceuticals (NASDAQ:ENTA) enters new coverage phase, highlighting biotech positioning and Nasdaq index relevance.
Beam Therapeutics (NASDAQ:BEAM) Price Targets Rise As Nasdaq Futures Move
March 27, 2026 08:23 AM PDT| By Anmol KhazanchiBeam Therapeutics (NASDAQ:BEAM) shows valuation movement, strong institutional participation, and biotech positioning amid Nasdaq futures trends.
ADMA Biologics (NASDAQ:ADMA) Addresses Market Attention As Nasdaq Today Reacts
March 27, 2026 07:50 AM PDT| By Anmol KhazanchiADMA Biologics (NASDAQ:ADMA) addresses allegations, reinforcing compliance and transparency as Nasdaq today highlights biotech sector sensitivity.
